(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Arcus Biosciences, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, April 23rd, 2024 | 2023 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 650,000 | 0 | 2,327,514 | 550,000 | 11,112 | 10,120,945 |
| Tuesday, April 23rd, 2024 | 2022 | Dimitry Nuyten, M.D., Ph.D. Chief Medical Officer | 225,000 | 0 | 1,105,000 | 160,000 | 337 | 4,605,026 |
| Tuesday, April 23rd, 2024 | 2023 | Dimitry Nuyten, M.D., Ph.D. Chief Medical Officer | 562,000 | 0 | 748,680 | 250,000 | 11,784 | 3,692,922 |
| Tuesday, April 23rd, 2024 | 2021 | Jennifer Jarrett Chief Operating Officer | 525,000 | 0 | 14,692,000 | 300,000 | 3,242 | 15,520,242 |
| Tuesday, April 23rd, 2024 | 2022 | Jennifer Jarrett Chief Operating Officer | 550,000 | 0 | 1,032,188 | 370,000 | 5,294 | 4,750,832 |
| Tuesday, April 23rd, 2024 | 2023 | Jennifer Jarrett Chief Operating Officer | 575,000 | 0 | 1,008,516 | 300,000 | 8,694 | 4,744,548 |
| Tuesday, April 23rd, 2024 | 2021 | Juan Carlos Jaen, Ph.D. President | 535,000 | 0 | 711,644 | 300,000 | 5,564 | 4,415,283 |
| Tuesday, April 23rd, 2024 | 2022 | Robert C. Goeltz, II Chief Financial Officer | 470,000 | 0 | 511,965 | 270,000 | 5,294 | 2,653,934 |
| Tuesday, April 23rd, 2024 | 2023 | Robert C. Goeltz, II Chief Financial Officer | 490,000 | 0 | 748,680 | 220,000 | 8,694 | 3,587,832 |
| Tuesday, April 23rd, 2024 | 2021 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 366,875 | 300,000 | 1,652,850 | 0 | 267,606 | 9,483,339 |
| Tuesday, April 23rd, 2024 | 2022 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 350,000 | 0 | 2,146,950 | 400,000 | 6,112 | 9,048,432 |
| Tuesday, April 23rd, 2024 | 2022 | Juan Carlos Jaen, Ph.D. President | 550,000 | 0 | 1,032,188 | 370,000 | 11,144 | 4,756,682 |
| Tuesday, April 23rd, 2024 | 2023 | Juan Carlos Jaen, Ph.D. President | 575,000 | 0 | 1,008,516 | 300,000 | 14,544 | 4,750,398 |
| Tuesday, April 23rd, 2024 | 2021 | Robert C. Goeltz, II Chief Financial Officer | 435,000 | 0 | 459,125 | 175,000 | 2,810 | 2,919,080 |
| Friday, April 21st, 2023 | 2020 | Jennifer Jarrett Chief Operating Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2022 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2021 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2020 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2022 | Robert C. Goeltz, II Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2021 | Robert C. Goeltz, II Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2022 | Juan Carlos Jaen, Ph.D. President and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2021 | Juan Carlos Jaen, Ph.D. President and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2022 | Jennifer Jarrett Chief Operating Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2021 | Jennifer Jarrett Chief Operating Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 21st, 2023 | 2022 | Dimitry Nuyten, M.D., Ph.D. | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 20th, 2022 | 2020 | William Grossman, M.D., Ph.D. Former Chief Medical Officer | 457,600 | 0 | 3,352,750 | 250,000 | 1,200 | 6,134,970 |
| Wednesday, April 20th, 2022 | 2020 | Robert C. Goeltz, II Chief Financial Officer | 175,000 | 0 | 0 | 75,000 | 300 | 3,757,300 |
| Wednesday, April 20th, 2022 | 2021 | Robert C. Goeltz, II Chief Financial Officer | 435,000 | 0 | 459,125 | 175,000 | 3,200 | 2,919,470 |
| Wednesday, April 20th, 2022 | 2019 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 340,000 | 0 | 0 | 0 | 1,200 | 1,716,900 |
| Wednesday, April 20th, 2022 | 2019 | Juan Carlos Jaen, Ph.D. President and Director | 500,000 | 0 | 0 | 250,000 | 1,200 | 2,126,900 |
| Wednesday, April 20th, 2022 | 2021 | Juan Carlos Jaen, Ph.D. President and Director | 535,000 | 0 | 711,644 | 300,000 | 3,200 | 4,412,919 |
| Wednesday, April 20th, 2022 | 2020 | Juan Carlos Jaen, Ph.D. President and Director | 515,000 | 0 | 1,652,750 | 275,000 | 1,200 | 3,787,650 |
| Wednesday, April 20th, 2022 | 2021 | Jennifer Jarrett Chief Operating Officer | 525,000 | 0 | 14,692,000 | 300,000 | 3,200 | 15,520,200 |
| Wednesday, April 20th, 2022 | 2020 | Jennifer Jarrett Chief Operating Officer | 125,000 | 0 | 90,150 | 75,000 | 28,171 | 10,896,760 |
| Wednesday, April 20th, 2022 | 2021 | Carolyn Tang General Counsel | 400,000 | 0 | 460,521 | 200,000 | 3,200 | 2,916,407 |
| Wednesday, April 20th, 2022 | 2020 | Carolyn Tang General Counsel | 337,515 | 0 | 958,650 | 175,000 | 1,200 | 2,239,445 |
| Wednesday, April 20th, 2022 | 2021 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 366,875 | 300,000 | 1,652,850 | 0 | 265,241 | 9,480,974 |
| Wednesday, April 20th, 2022 | 2020 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 325,625 | 0 | 3,005,000 | 0 | 1,200 | 5,683,300 |
| Wednesday, April 20th, 2022 | 2021 | William Grossman, M.D., Ph.D. Former Chief Medical Officer | 317,263 | 0 | 688,688 | 0 | 2,900 | 3,926,548 |
| Wednesday, April 20th, 2022 | 2019 | William Grossman, M.D., Ph.D. Former Chief Medical Officer | 296,667 | 200,000 | 0 | 180,000 | 600 | 3,400,307 |
| Tuesday, April 20th, 2021 | 2019 | William Grossman, M.D., Ph.D. Chief Medical Officer | 296,667 | 200,000 | 0 | 180,000 | 600 | 3,400,307 |
| Tuesday, April 20th, 2021 | 2020 | Jennifer Jarrett | 125,000 | 0 | 90,150 | 75,000 | 28,171 | 10,896,760 |
| Tuesday, April 20th, 2021 | 2020 | William Grossman, M.D., Ph.D. Chief Medical Officer | 457,600 | 0 | 3,352,750 | 250,000 | 1,200 | 6,134,970 |
| Tuesday, April 20th, 2021 | 2020 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 325,625 | 0 | 3,005,000 | 0 | 1,200 | 5,683,300 |
| Tuesday, April 20th, 2021 | 2019 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 340,000 | 0 | 0 | 0 | 1,200 | 1,716,900 |
| Tuesday, April 21st, 2020 | 2019 | Rekha Hemrajani | 233,818 | 200,000 | 0 | 0 | 142,266 | 3,558,524 |
| Tuesday, April 21st, 2020 | 2019 | William Grossman, M.D., Ph.D. | 296,667 | 200,000 | 0 | 180,000 | 600 | 3,400,307 |
| Tuesday, April 21st, 2020 | 2019 | Juan Carlos Jaen, Ph.D. President and Director | 500,000 | 0 | 0 | 250,000 | 1,200 | 2,126,900 |
| Tuesday, April 21st, 2020 | 2018 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 295,000 | 0 | 0 | 0 | 1,200 | 1,124,479 |
| Tuesday, April 21st, 2020 | 2019 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 340,000 | 0 | 0 | 0 | 1,200 | 1,716,900 |
| Tuesday, April 21st, 2020 | 2018 | Juan Carlos Jaen, Ph.D. President and Director | 350,000 | 0 | 0 | 0 | 1,200 | 1,179,479 |
| Monday, April 22nd, 2019 | 2018 | Juan Carlos Jaen President and Director | 350,000 | 0 | 0 | 0 | 1,200 | 1,179,479 |
| Monday, April 22nd, 2019 | 2018 | Jennifer Jarrett Former Chief Operating Officer and Chief Financial Officer | 435,938 | 0 | 0 | 200,000 | 1,200 | 3,303,785 |
| Monday, April 22nd, 2019 | 2017 | Juan Carlos Jaen President and Director | 350,000 | 0 | 0 | 0 | 1,200 | 461,975 |
| Monday, April 22nd, 2019 | 2018 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 295,000 | 0 | 0 | 0 | 1,650 | 1,124,929 |
| Monday, April 22nd, 2019 | 2017 | Jennifer Jarrett Former Chief Operating Officer and Chief Financial Officer | 333,333 | 0 | 0 | 100,000 | 900 | 895,057 |
| Monday, April 22nd, 2019 | 2017 | Terry Rosen, Ph.D. Chief Executive Officer and Director | 314,780 | 0 | 0 | 0 | 1,200 | 426,755 |
